<DOC>
	<DOCNO>NCT02501213</DOCNO>
	<brief_summary>While author recommend diuretic first treatment initiate symptom cause malignant ascites ( MA ) , prescription variable . No randomized , control study assess benefit context . According literature , diuretic may bring relief 40 % case , regardless primary tumor . The purpose study assess effectiveness diuretic treatment accord Serum Ascites Albumin Gradient ( SAAG ) measure treatment . Judgment criteria time elapse recurrent MA require paracentesis . The investigator also examine whether SAAG serum level renin aldosterone predict symptom response diuretic .</brief_summary>
	<brief_title>Evaluation Efficacy Diuretics Symptomatic Malignant Ascites Episodes Advanced Stage Cancer ( DIASC )</brief_title>
	<detailed_description>Patients eligible trial sign consent participate randomize arm A B . Treatment order randomly attribute patient 1st paracentesis , reception laboratory result necessary evaluate SAAG value . Randomization stratify 1:1 accord SAAG value ( ≥ &lt; 11g/L ) Systemic treatment ( yes ) - Patients randomize arm A observed next episode require paracentesis ( due clinical symptom : abdominal pain heaviness , dyspnoea , orthopnoea , nausea/vomiting , anorexia , early satiety , gastro-oesophageal reflux , low limb genital oedema ) , time receive arm B ( diuretic ) , absence contra-indication diuretic treatment . - Patients randomized arm B receive diuretic next episode require paracentesis , time receive arm A ( observation ) . Patients physical assessment within 24 hour prior start treatment , every two week patient randomize arm A week patient randomize arm B , cross-over end study . Patient also biological assessment within 24 hour prior start treatment , twice week patient randomize arm B , cross-over end study . Finally , address quality life questionnaire ( QLQ-C15-PAL ) prior start treatment , cross-over end study .</detailed_description>
	<mesh_term>Ascites</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<criteria>Patients advanced stage cancer First episode malignant ascites Grade 2 3 ascites Clinically symptomatic ascites require paracentesis due : abdominal pain heaviness , dyspnoea , orthopnoea , nausea/vomiting , anorexia , early satiety , gastrooesophageal reflux , low limb genital oedema Age ≥ 18 year Performance status ≤ 3 Life expectancy ≥ 1 month Absence contraindication diuretic treatment Patient regularly follow palliative care supportive care team Signed date informed consent Hepatic disorder : cirrhosis , hepatitis , hepatocellular insufficiency , hepatic encephalopathy Non malignant ascites Hydroelectrolytic disorder : hyponatremia ( &lt; 130 mmol/L ) hyperkaliemia ( &gt; 5 mmol/L ) severe hypokaliemia ( &lt; 3 mmol/L ) Functional acute renal insufficiency Urinary disorder : Obstruction urinary tract , Oliguria/anuria Chronic renal failure Patient unable swallow Sulfamides allergy Hypersensitivity spironolactone excipients Hypersensitivity furosemide excipients Pregnant breastfeed woman Patient guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Diuretic</keyword>
	<keyword>Malignant ascites</keyword>
</DOC>